CAS 252343-27-4

(S)-8,14-Dihydroxy Efavirenz

Produit contrôlé

CAS : 252343-27-4

Applications (S)-8,14-Dihydroxy Efavirenz, is a metabolite of Efavirenz (E425000), a nonnucleoside HIV-1 reverse transcriptase inhibitor. Antiviral.
References Young, S.D., et al.: Antimicrob. Ag. Chemother., 39, 2602 (1995),

Formule : C₁₄H₉ClF₃NO₄

Couleur et forme : Neat

Masse moléculaire : 347.67

Ref: TR-D468240

(S)-8,14-Dihydroxy efavirenz

CAS : 252343-27-4

(S)-8,14-Dihydroxy efavirenz is a medicinal analog that has shown potential anticancer activity. It is a kinase inhibitor that targets specific kinases involved in cancer cell growth and survival. (S)-8,14-Dihydroxy efavirenz has been shown to induce apoptosis in human cancer cells and inhibit tumor growth in Chinese hamster ovary cells. This compound also has potential as a urinary biomarker for certain types of cancer. Its protein binding properties make it an effective inhibitor of kinases, which are essential for cellular processes such as DNA replication and protein synthesis. (S)-8,14-Dihydroxy efavirenz has promising potential as an anticancer agent and warrants further investigation.

Formule : C₁₄H₉ClF₃NO₄

Degré de pureté : Min. 95%

Masse moléculaire : 347.67 g/mol

Ref: 3D-CKA34327